Career Enhancement Program
Career Enhancement Program
批准号:
10436170
负责人:
Alice Berger
金额:
$8.18万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-01 至 2024-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract – Career Enhancement Program
The development of talented junior faculty into future leaders in their respective fields is a key goal of essential
all successful research organizations. The Fred Hutch Lung SPORE Career Enhancement Program (CEP) will
aspire to identify and nurture the careers of promising junior investigators and senior faculty interested in re-focusing their programs on lung cancer translational research. This will be accomplished through a calculated
solicitation process to identify all talented junior investigators at the post-doctoral fellow level (must be in last
year of training) and junior faculty level. We will also solicit applications from senior investigators who wish to
re-focus their research programs on translational lung cancer research. A thorough review process will be
performed by a highly accomplished panel of senior leaders at our Center who comprise the CEP Committee.
In conjunction with the Executive Committee (EC), final award decisions will be made. The CEP Committee will
closely monitor the progress of CEP Awardees throughout the duration of the award. The EC and CEP
Committee will ensure that the awardees become immersed within the Lung SPORE and benefit the research
expertise and available core resources. Self-assessments will be made by the Committee such that the
effectiveness of the program can be carefully monitored and necessary adjustments made. Ongoing efforts at
our Center will be leveraged to promote an environment of inclusion in which gender and ethnic diversity is
promoted within the Lung SPORE.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer
-
批准号:10211377
-
项目类别:
-
资助金额:$46.74万
-
财政年份:2021
-
负责人:Alice Berger
-
依托单位:
Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer
-
批准号:10746367
-
项目类别:
-
资助金额:$13.57万
-
财政年份:2021
-
负责人:Alice Berger
-
依托单位:
Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer
-
批准号:10641671
-
项目类别:
-
资助金额:$45.8万
-
财政年份:2021
-
负责人:Alice Berger
-
依托单位:
Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer
-
批准号:10378686
-
项目类别:
-
资助金额:$46.74万
-
财政年份:2021
-
负责人:Alice Berger
-
依托单位:
Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer
-
批准号:10746645
-
项目类别:
-
资助金额:$7.78万
-
财政年份:2021
-
负责人:Alice Berger
-
依托单位:
Investigating the role of the small GTPase RIT1 in lung adenocarcinoma
-
批准号:9381072
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2016
-
负责人:Alice Berger
-
依托单位:
Investigating the role of the small GTPase RIT1 in lung adenocarcinoma
-
批准号:9113528
-
项目类别:
-
资助金额:$2.26万
-
财政年份:2015
-
负责人:Alice Berger
-
依托单位:
国内基金
海外基金
胚胎脑发育的分子机理:lgl2(late gestation lung 2)蛋白质的生物学功能的研究
-
批准号:30470854
-
项目类别:面上项目
-
资助金额:18.0万元
-
批准年份:2004
-
负责人:陶涛
-
依托单位: